Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN112239456B details a safe Pd-catalyzed carbonylation route for 2,3-dihydroquinolones, offering high yields and simplified supply chains for API manufacturers.
Novel 4-step Crizotinib process improves yield to 35%. Reduces steps for reliable pharmaceutical intermediates supplier cost efficiency.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazol-3-ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN111777564B details a green aqueous photocatalytic method for quinazolinones using KI, offering cost-effective and scalable production for pharmaceutical intermediates.
Novel sulfur-promoted method for high-purity triazole intermediates. Cost-effective metal-free process ensuring supply chain reliability for pharmaceutical manufacturing partners seeking scalable solutions.
Novel iodine-promoted route for 3,4,5-trisubstituted 1,2,4-triazoles offers metal-free efficiency and scalable production for global API manufacturers.
Patent CN115925692A details Rh-catalyzed C-H activation for trifluoromethyl enamines. High yields, scalable process for drug discovery.
Novel heating-promoted synthesis of 2-trifluoromethyl quinoline intermediates. Catalyst-free process ensures cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114160206B details a novel chiral copper catalyst achieving >91% ee and >81% yield for 3-alkenyl-3-substituted oxindoles, offering scalable API intermediate solutions.
Novel Pd-catalyzed serial cyclization for beta-halopyrroles. High purity, scalable process for pharma intermediates. Cost-effective supply chain solution.
Patent CN113429349A details a Cu/g-C3N4 catalyzed route for high-purity benzimidazoles, offering scalable production and cost-effective manufacturing solutions.
Novel Pd-catalyzed C-H activation method for 2-perfluoroalkyl indoles. Green oxidation, high regioselectivity, scalable for pharmaceutical intermediates.
Patent CN112239456B details a safe palladium-catalyzed carbonylation route for 2,3-dihydroquinolones, offering reliable pharmaceutical intermediate supply chains.
Patent CN114539198B reveals novel Pd-catalyzed route. Delivers cost reduction and supply chain reliability for pharmaceutical manufacturing processes globally.
Patent CN115246807B reveals novel thioester synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with high-purity output and scalable processes.
Patent CN105936623B reveals a mild copper-catalyzed route to 3,4-cyclopentyl-1-tetralone, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN112480015B details a Pd-catalyzed one-pot method for 2-trifluoromethyl quinazolinones, offering cost reduction in API manufacturing and scalable supply chain solutions.
Patent CN115215810B reveals a catalyst-free heating method for triazole synthesis, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115385916B reveals high-yield chiral synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing globally.
Novel palladium-catalyzed pathway for indolone thioesters using sulfonyl chloride. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediate production significantly.